Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-10 |
mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 5e-10 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.24 | 6e-09 |
mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.2 | 1e-08 |
mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-08 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-08 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-07 |
mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-07 |
mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.2 | 2e-07 |